3rd Feb 2011 10:34
Immunodiagnostic Systems Holdings plc
("IDS" or "the Company")
Issue of Share Options
Immunodiagnostic Systems Holdings plc ("IDS" or "the Company"), a leading producer of diagnostic testing kits for the clinical and research markets, announces that Martha Garrity, Technical Director, has been awarded the following share options to subscribe for ordinary shares of 2p each in the capital of the Company ("Ordinary Shares"):
Exercise Price | Number of Shares | Date from which exercisable | Expiry date |
852.5p | 20,000 | 3rd February 2014 | 3rd February 2021 |
The options were granted under the Company's Unapproved Share Option Scheme. The exercise of options granted is subject to the achievement of certain performance conditions set by the Board.
For further information:
Immunodiagnostic Systems Holdings plc | Tel: 0191 519 0660 |
Ian Cookson, CEO | |
Paul Hailes, Finance Director | |
Brewin Dolphin | Tel: 0845 213 4730 |
Matt Davis | |
Sean Wyndham-Quin | |
Walbrook PR Ltd | Tel: 020 7933 8787 |
Paul McManus | Mob: 07980 541 893 |
Related Shares:
IDH.L